| Financial Year |
September 30 2022 |
| Monetary Funds |
3,727,965.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,447,346.65 |
| Advances to Suppliers |
105,860,951.42 |
| Other Receivables |
2,513,857.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
145,108,401.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
604,733.55 |
| Total Current Assets |
261,263,255.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
390,088,807.50 |
| Under-construction Projects |
959,550.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,567,141.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,126,393.04 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
553,761,883.94 |
| Total Assets |
815,025,139.33 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
277,485,570.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,725,516.57 |
| Taxes Payable |
80,429,870.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,700,999.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,310,010.57 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
486,469,778.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
385,893,682.13 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
510,338,648.90 |
| Total Liabilities |
996,808,427.17 |
| Paid-In Capital(Or Share Stock) |
665,600,000.00 |
| Capital Surplus |
264,602,161.73 |
| Surplus Reserve |
52,379,058.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,164,364,507.92 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-181,783,287.84 |
| Owner's Equity（Stockholder's Equity） |
-181,783,287.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
815,025,139.33 |
